{"title":"Validity of Inertial Measurement Unit (IMU Sensor) for Measurement of Cervical Spine Motion, Compared with Eight Optoelectronic 3D Cameras Under Spinal Immobilization Devices","authors":"Wijittra Liengswangwong, Natcha Lertviboonluk, C. Yuksen, P. Jamkrajang, Weerawat Limroongreungrat, Atipong Mongkolpichayaruk, Chestsadakon Jenpanitpong, Sorawich Watcharakitpaisan, Chantarat Palee, Picharee Reechaipichitkool, Suchada Thaipasong","doi":"10.2147/mder.s475166","DOIUrl":"https://doi.org/10.2147/mder.s475166","url":null,"abstract":"","PeriodicalId":517620,"journal":{"name":"Medical Devices: Evidence and Research","volume":"55 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141689250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Triwiyanto, B. Utomo, Sari Lutfiyah, I. Putu, Alit Pawana
{"title":"Lesson Learned from Mass Antibody Rapid Diagnostic Used in the Early COVID-19 Pandemic in Indonesia Contributors [Letter]","authors":"Triwiyanto, B. Utomo, Sari Lutfiyah, I. Putu, Alit Pawana","doi":"10.2147/mder.s478030","DOIUrl":"https://doi.org/10.2147/mder.s478030","url":null,"abstract":"We are writing in response to the in-depth findings presented in the article entitled “Lesson Learned from Mass Antibody Rapid Diagnostic Used in the Early COVID-19 Pandemic in Indonesia Contributors” by Indrati et al, 1 published in Medical Devices: Evidence and Research. This study reveals a comprehensive analysis of the performance and characteristics of SARS-CoV-2 antibody rapid diagnostic tests (RDTs) used in the early phase of the COVID-19 outbreak in Indonesia. The authors conducted a comprehensive evaluation of various antibody RDTs, including total, IgG, and IgM, to assess the accuracy of the diagnostic results and their utility in differentiating between past and current infections. Furthermore, a comprehensive examination of sample characteristics, including the diversity in sample status and type, enhances our comprehension of the practical applications of these diagnostic tools in real-world settings. 2 In conclusion, this paper makes a significant contribution to the field by offering valuable findings regarding the effectiveness and challenges associated with using antibody RDTs for the diagnosis of COVID-19. Although this study provides valuable and outstanding findings, it also highlights several weaknesses and limitations that need to be considered. One significant limitation of this study is its retrospective nature, which may introduce bias and limitations in data interpretation. Furthermore, the heterogeneity of the screening process and the relatively small sample size for some brands of antibody RDTs may impact the validity and generalizability of the findings. 3 Furthermore, this study identified common technical issues, such as unclear or invalid results, which underscores the necessity for enhanced standardization and quality control measures in the manufacture and application","PeriodicalId":517620,"journal":{"name":"Medical Devices: Evidence and Research","volume":"81 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141135894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kara J. Bragg, Michael Albus, Bradley Bragg, Rachelle Beste, Leslie Simon
{"title":"Evaluation of the Functionality in an Emergency Department Setting of an Intravenous Protection Device to Prevent Self-Injection","authors":"Kara J. Bragg, Michael Albus, Bradley Bragg, Rachelle Beste, Leslie Simon","doi":"10.2147/mder.s451439","DOIUrl":"https://doi.org/10.2147/mder.s451439","url":null,"abstract":"Background: The United States has an opioid abuse crisis that has been increasing exponentially since 2013. In 2021, there were 220 deaths each day from opioid overdoses in the United States alone. Patients suffering from addiction often present to the emergency department (ED) anticipating that an intravenous (IV) catheter will be placed. This catheter is then accessible for patients to self-inject illicit drugs while under medical care or elope from the facility with the IV in place to self-inject. The misuse of medical IV access is a potential source of prolonged hospitalizations and fatal overdoses nationwide. On two separate occasions, patients were found dead in our ED bathroom after overdosing by accessing their IV site for self-injection. These events prompted the development of the IV SafeLock prototype. The IV SafeLock is designed to prevent intravenous access by the patient while allowing access by specified providers to administer medications. This study aims to investigate prototype usability and functionality by nursing staff in the ED. Methods: A prospective study was performed with twenty ED nurses in a clinical trial to use the IV SafeLock in the clinical setting. Each nurse was given two months to complete an evaluation of 20 patients requiring IV access. They used the IV SafeLock on infusion ports and Intermittent Needle Therapy (INT) access sites. A Likert scale was used to measure the ease of function and use of the IV SafeLock. Results and conclusion: The nurses felt that the IV SafeLock was easy to use and achieved its function of protecting the intravenous access site from self-injection. The IV SafeLock prototypes used in the trial were easy to use and functioned as intended most of the time. The IV SafeLock can be used by nursing staff in a clinical setting to help prevent self-injection. Clinical Trial","PeriodicalId":517620,"journal":{"name":"Medical Devices: Evidence and Research","volume":"59 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}